HLB PANAGENE Co., LTD. Logo

HLB PANAGENE Co., LTD.

A global leader in PNA technology for cancer diagnostics and precision medicine.

046210 | KO

Overview

Corporate Details

ISIN(s):
KR7046210001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 54, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB PANAGENE Co., LTD. is a global molecular diagnostics company specializing in the development and commercialization of products based on its proprietary Peptide Nucleic Acid (PNA) technology. As a leading worldwide supplier of PNA materials, the company provides innovative solutions for in-vitro diagnostics (IVD), companion diagnostics (CDx), and liquid biopsy, primarily targeting oncology and precision medicine. Its portfolio includes diagnostic kits for detecting cancer-related mutations, such as the PANA Mutyper™ series for lung cancer. The company is actively expanding its global market presence and is integrating Artificial Intelligence (AI) to develop a next-generation multimodal diagnostic platform, aiming to advance personalized healthcare and cancer diagnostics. Formerly known as Panagene Inc., the company changed its name in 2023.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.6 KB
2025-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 101.6 KB
2025-08-20 00:00
Capital/Financing Update
주권관련사채권의취득결정
Korean 38.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-18 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-07-18 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 15.2 KB
2025-07-18 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 14.3 KB
2025-06-05 00:00
Share Issue/Capital Change
전환청구권행사
Korean 11.3 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 230.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-14 00:00
Share Issue/Capital Change
전환청구권행사
Korean 11.3 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.3 KB
2025-04-18 00:00
Capital/Financing Update
전환가액의조정
Korean 16.4 KB

Automate Your Workflow. Get a real-time feed of all HLB PANAGENE Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PANAGENE Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PANAGENE Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.